Immuno-oncology company Agenus to cut 50 jobs in reorganization
This article was originally published here
Clinical-stage immuno-oncology firm Agenus is reorganizing its business and operations to straighten its focus on clinical development of its two checkpoint inhibitor antibodies and vaccine program.
Leave a Reply
Want to join the discussion?Feel free to contribute!